Tenzing Acquisition in an 8-K filing today said shareholders voted to merge with pharmaceuticals company Reviva. The deal gives the combined company a valuation of $119 million. Read more.
Shareholders Approve Tenzing/Reviva Merger
Related Posts
Corner Growth Acquisition 2 Wants 9 More Months to do a Deal
The company originally raised $185 million in a June 2021 IPO to focus on the technology industry in the United States and other developed countries. The trust as of Feb. 23 was just under $22 million.
Venus Acquisition Files Prelim Proxy on VIYI Deal
As announced in June 2021, terms provide for a valuation of VIYI Algo and its subsidiaries and businesses of $400 million.
OmniLit Shareholders Approve Syntec Optics Combination
Syntec is an optics and photonics company for scientific and technical instruments, and aerospace and defense.
Dune Closes $172.5M IPO
The SPAC said it intends to target SaaS companies.